Yazen expands in Scandinavia through acquisition of Danish Medstart
CSP
3 min read
11

Yazen expands in Scandinavia through acquisition of Danish Medstart

December 18, 2024
0

Reading Time: 3 minutes Yazen, the leading digital healthcare provider for obesity treatment, has acquired the Danish company Medstart. Medstart, established in Denmark and Norway, shares Yazen’s holistic approach to obesity care, making this acquisition a natural step in Yazen’s ambitious growth journey. Oliver Willacy,

Continue Reading
How to Protect Your Home From Strong Winds
CSP
6 min read
48

How to Protect Your Home From Strong Winds

December 18, 2024
0

Reading Time: 4 minutes   Strong winds can inflict some serious damage on homes, ranging from minor roof damage to severe structural failure. To help safeguard your property and your family, it is crucial to implement some proactive measures to protect your home from the

Continue Reading
AIT Worldwide Logistics Secures ISO Quality, Safety, and Sustainability Certifications Across Asia
BWI
4 min read
36

AIT Worldwide Logistics Secures ISO Quality, Safety, and Sustainability Certifications Across Asia

December 18, 2024
0

Reading Time: 3 minutes Itasca, Ill., United States:   AIT Worldwide Logistics, a leading global supply chain solutions provider, is proud to announce that more than a dozen of its locations across five countries in Asia have secured ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and ISO

Continue Reading
CSP
2 min read
4

Director/PDMR Shareholding – Lancashire Holdings Ltd

December 18, 2024
0

Reading Time: < 1 minute Lancashire Holdings Limited (the “Company”) or (“LHL”)   Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them     17 December 2024 Hamilton, Bermuda The Company announces that on 13 December 2024,

Continue Reading
CSP
4 min read
8

Grant of new warrants in connection with loan

December 18, 2024
0

Reading Time: 3 minutes MapsPeople A/S | Grant of warrantsCompany Announcement No. 29 – 2024Aalborg, December 17, 2024 Grant of warrants As communicated in Company Announcement No. 20 – 2024, MapsPeople has entered into a loan agreement with Danmarks Eksport- and Investeringsfond (“EIFO”) of up

Continue Reading
CSP
2 min read
50

Medius Announces 2024 Customer Innovation Award Winners

December 18, 2024
0

Reading Time: 2 minutes Award winners span across categories including Fraud & Risk Mitigation, Spend Excellence, Medius Evangelism, Autonomous Processing and Global Rollout. Medius, a leading provider of Accounts Payable (AP) Automation and wider Spend Management solutions, announced today the winners of its 2024 Customer

Continue Reading
CSP
1 min read
48

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 17.12.2024

December 17, 2024
0

Reading Time: < 1 minute Stock Exchange Release 17.12.2024 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 17.12.2024   Date 17.12.2024   Exchange transaction Buy   Share class FSKRS   Amount  2,000   Average price/share 14.3668 EUR Highest price/share 14.3800 EUR Lowest price/share

Continue Reading
CSP
1 min read
51

ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 17.12.2024

December 17, 2024
0

Reading Time: < 1 minute   ALEXANDRIA GROUP OYJ NOTIFICATION     17.12.2024 at 18:30 EET   ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 17.12.2024   Date 17.12.2024   Exchange transaction Buy   Share class ALEX   Amount 260   Average price/share 8.5500 EUR Highest

Continue Reading
CSP
1 min read
48

Nordea Bank Abp: Repurchase of own shares on 17.12.2024

December 17, 2024
0

Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares17.12.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 17.12.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average

Continue Reading
CSP
11 min read
48

Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome

December 17, 2024
0

Reading Time: 8 minutes Lund, Sweden, 17 December 2024. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), today announced positive full results from the 15-HMedIdeS-09 single arm Phase 2 study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome (GBS) and an indirect treatment

Continue Reading